Our findings demonstrate that the IRS RNA-expression profiles were a valuable prognostic panel in all BLCA cohorts (Figure 7F-H, Figure S26A-D, Figure S27, Figure S28). This evidence concerns the gene IARS1 and bladder transitional cell carcinoma.